Bettering Ourselves

The pursuit of perfection demands that we
be open-minded and willing to take risks
and challenge ourselves to learn everything
we can in our field of expertise. Let us pause
to consider some of the innovations of the
past decade to help us ha…

FDA raises concerns about cross-linking system in complete response letter to Avedro

Avedro received a complete response letter from the FDA regarding the new drug application for its riboflavin ophthalmic solution/KXL system for corneal cross-linking, according to a press release.In the letter, the FDA stated that it has identified a “small number of areas on the application” that require additional information concerning the device, but none of which pertains to the clinical study safety or efficacy data presented in the application, the release said.